AIM PAPYRSign in

Development of innovative antimicrobials against pathogens resistant to antimicrobials

Directly managed European call · HORIZON-HLTH-2027-01-DISEASE-08

The title is in English, the language of the official source.

A consortium is required.

The general EU rules ask for at least three independent legal entities from three Member States or associated countries. An SME cannot apply on its own.

Framework call: Cluster 1 - Health (Single stage - 2027/1) · HORIZON-HLTH-2027-01

Topics: Antibiotics, Antimicrobial resistance, Antimicrobials, Clinical development, Phase I, Clinical trials, Disease control, Drug development, clinical phases, Fungi, Infectious diseases, MRSA, Patient safety

See the call on the European Commission portal

Follow it in My grants. We alert you when the next cut-off is near and you keep it alongside your company's other grants.

Partners for the consortium

Organisations from other countries that have already taken part in 1 Horizon Europe projects, chosen by similar topics. Those from Spain are not shown.

OrganisationCountryTypeProjectsAn example project
ANTABIOFranceCompany · SME1sbli-ant3310 (2023)

Countries with the most organisations: France (1).

That an organisation has taken part before does not mean it is looking for partners now: it is a starting point for finding whom to approach. Each applicant decides its consortium.

Origen de los datos: CORDIS, Comisión Europea.

Other calls under Horizon Europe

All calls under Horizon Europe

We classify each call by its official type of action and the general EU rules: collaborative research and innovation actions ask, as a rule, for three entities from three countries; many coordination and support actions and prizes accept a single entity; the EIC Accelerator is for a single company. Whatever the programme regulation does not set stays under “it depends”. The official text of each call prevails.

Origen de los datos: portal Funding & Tenders de la Comisión Europea (datos abiertos).